TrueTear in Sjogren's Disease Patients

Exclusion Criteria

• •Use of any topical ophthalmic medication, including artificial tears, within 4 hours of either visit
• •Chronic or recurrent epistaxis, coagulation disorders or other conditions that, in the opinion of the investigator, may lead to clinically significant increased bleeding
• •Use of systemic anticoagulants
• •Nasal or sinus surgery including nasal cautery or significant trauma
• •Severely deviated septum
• •Cardiac demand pacemaker, implanted defibrillator or other implanted electronic device
• •Have an active implanted metallic or active implanted electronic device in the head, a cardiac demand pacemaker, or an implanted defibrillator
• •Known hypersensitivity to any of the procedural agents or materials in the study device that contact the nasal mucosa
• •Corneal transplant in either or both eyes
• •Participation in any clinical trial within 30 days of the Screening Visit
• •A woman who is pregnant, planning a pregnancy, or nursing at the Screening Visit